Investment and expertise
for promising, early-stage
Scottish technology and
life science companies.
WHAT WE DO
We are a prominent
business angel syndicate,
which has been at the
forefront of early stage
investing in Scotland for
more than two decades.
SEE OUR MEMBER BENEFITS
We invest in companies
from the technology,
software and life sciences
sectors – three markets in
which Scotland produces
a wealth of talent.
SEE IF YOU MEET THE CRITERIA

Originally formed in 1992 and based in Edinburgh, Archangels is a prominent business angel syndicate which has been at the forefront of early stage investing in Scotland for more than a quarter of a century.

Latest News

Sorting:
  • Flexitricity receives backing to launch new products and services

    Creator of the first and most advanced smart grid in the UK prepares for 2012 expansion. Edinburgh, UK – 16 January 2012 – Flexitricity, a UK Company, (www.flexitricity.com) today announced a further investment from Archangel Informal Investments, its current investors, to fund new activity. Source: New feed

  • Reactec make the Deloitte UK Technology Fast 50

    Reactec has been ranked 48th in the UK and 4th in Scotland in the Deloitte UK Technology Fast 50 listing. Source: New feed

  • Touch Bionics set for “a major period of expansion” after securing £2.5 million in new investment.

    Touch Bionics, the Scottish prosthetic technology group, is set for “a major period of expansion” after securing £2.5 million in new investment. The group, whose artificial hands have helped rehabilitate wounded service personnel in the UK and overseas, has won support from Scotland’s biggest provider of angel funding Archangels and matching funding from the Scottish […]

  • ‘Exceptional’ drug to battle superbugs unveiled by Scottish firm

    A GROUNDBREAKING antibiotic treatment to tackle hospital superbugs is being developed by Scottish scientists. Researchers at Glasgow-based firm MGB Biopharma have created a form of treatment which they believe is far more effective at treating both MRSA and C Clostridium difficile (C Diff) than current drugs used to battle the infections, which are often picked […]

  • Touch Bionics unveils new products at AOPA

    Prosthetics technology company continues to innovate.Las Vegas, NV – September 20, 2011 – Touch Bionics®, the upper limb prosthetic technology provider, today revealed new and upgraded products at the American Orthotic & Prosthetic Association National Assembly in Las Vegas. Source: New feed

  • Mpathy Medical Devices sale wins

    Mpathy Medical Devices wins Deals:Dealmakers 2011 – Small/ Mid size deal of the year award. Source: New feed

Company portfolio

  • RT @OvensDavid: Nice to talk to @DJohnsonMSP today about the importance of angel investing to the Scottish economy and the great work which…
    Archangel Investors Ltd about 2 days ago

See our ‘Impact evaluation of activities report’ by the Hunter Centre for Entrepreneurship at The University of Strathclyde.